Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.

Huisman, Albert; Beun, Robert; Sikma, Maaike; Westerink, Jan; Kusadasi, Nuray

Huisman, Albert; Beun, Robert; Sikma, Maaike; Westerink, Jan; Kusadasi, Nuray.

Huisman A; Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Beun R; Department of Intensive Care, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Sikma M; Department of Intensive Care, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Westerink J; Dutch Poisons Information Center, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Kusadasi N; Department of Vascular Medicine, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.

Int J Lab Hematol ; 42(5): e211-e212, 2020 10.

Article in English | MEDLINE | ID: covidwho-343638

Subject(s)

ADAMTS13 Protein/blood; COVID-19/blood; Thromboembolism/virology; von Willebrand Factor/metabolism; Adult; Aged; Aged, 80 and over; COVID-19/physiopathology; Female; Humans; Male; Middle Aged; Thromboembolism/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / Von Willebrand Factor / ADAMTS13 Protein / COVID-19 Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Int J Lab Hematol Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Ijlh.13244

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google